Viropro Stock Price Prediction
As of today the rsi of Viropro's share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Viropro's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Viropro, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Viropro's stock price prediction:
To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.
Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Revenue Growth 1.19 |
Using Viropro hype-based prediction, you can estimate the value of Viropro from the perspective of Viropro response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Viropro to buy its stock at a price that has no basis in reality. In that case, they are not buying Viropro because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Viropro after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Viropro Basic Forecasting Models to cross-verify your projections. Viropro Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Viropro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viropro backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Viropro, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Viropro Hype Timeline
Viropro is at this time traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Viropro is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Viropro is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has Price to Book (P/B) ratio of 1.17. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viropro had not issued any dividends in recent years. The entity had 1:12.14 split on the 26th of November 2003. Given the investment horizon of 90 days the next projected press release will be any time. Check out Viropro Basic Forecasting Models to cross-verify your projections.Viropro Related Hype Analysis
Having access to credible news sources related to Viropro's direct competition is more important than ever and may enhance your ability to predict Viropro's future price movements. Getting to know how Viropro's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Viropro may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| YECO | Yulong Eco Materials | 0.00 | 0 per month | 0.00 | (0.06) | 0.00 | (4.71) | 42.46 | |
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | (0.02) | 7.69 | (9.80) | 50.43 | |
| SYBE | SYBLEU INC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 7.48 | 0.07 | 27.59 | (15.45) | 64.24 | |
| BITRF | Biotron Limited | 0.02 | 7 per month | 0.00 | 0.15 | 0.00 | (18.75) | 1,057 | |
| TSOI | Therapeutic Solutions International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MCET | Multicell Techs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| JRSS | JRSIS Health Care | (0.01) | 3 per month | 12.72 | 0.15 | 65.29 | (37.95) | 214.12 | |
| CAFS | Caf Serendipity Holdings | 0.00 | 0 per month | 0.00 | 0.12 | 10.81 | 0.00 | 3,028 | |
| PRCNF | Pure Global Cannabis | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Viropro Additional Predictive Modules
Most predictive techniques to examine Viropro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Viropro using various technical indicators. When you analyze Viropro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Viropro Predictive Indicators
The successful prediction of Viropro stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Viropro, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Viropro based on analysis of Viropro hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Viropro's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Viropro's related companies. | 2010 | 2011 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.0226 | 7.64E-4 | 8.79E-4 | 8.35E-4 | Revenue Per Share | 0.007588 | 0.002307 | 0.002653 | 0.002521 |
Story Coverage note for Viropro
The number of cover stories for Viropro depends on current market conditions and Viropro's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Viropro is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Viropro's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Viropro Basic Forecasting Models to cross-verify your projections. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viropro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth 1.19 |
The market value of Viropro is measured differently than its book value, which is the value of Viropro that is recorded on the company's balance sheet. Investors also form their own opinion of Viropro's value that differs from its market value or its book value, called intrinsic value, which is Viropro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viropro's market value can be influenced by many factors that don't directly affect Viropro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viropro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.